mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |